Anticancer Res
-
Publication Venue For
- Double Negativity for Expression of YAP1 and CDX2 Defines an Aggressive Type of Colitis-associated Cancer.. 40:5411-5416. 2020
- Higher BMI, But Not Sarcopenia, Is Associated With Pembrolizumab-related Toxicity in Patients With Advanced Melanoma.. 40:5245-5254. 2020
- Textbook Outcomes Among Patients Undergoing Retroperitoneal Sarcoma Resection.. 40:2107-2115. 2020
- Chemotherapy or Combined Modality Therapy for Early-stage Hodgkin Lymphoma.. 38:2875-2881. 2018
- Update on Surgical Management of Small Bowel Neuroendocrine Tumors.. 38:1267-1278. 2018
- Neuroendocrine Neoplasms of the Appendix: A Review of the Literature.. 38:601-611. 2018
- Microsatellite Instability Is Common in Colorectal Cancer in Native Nigerians.. 37:2649-2654. 2017
- Plasma Metabolites and Risk of Radiation-induced Esophagitis: A Secondary Analysis from a Prospective Study.. 37:719-725. 2017
- The clinical significance of activated p-AKT expression in peripheral T-cell lymphoma.. 35:2465-2474. 2015
- Survival of patients undergoing cytoreductive surgery for metastatic renal cell carcinoma in the targeted-therapy era.. 34:2405-2411. 2014
- c-MET and HGF mRNA expression in hepatocellular carcinoma: correlation with clinicopathological features and survival.. 33:3241-3245. 2013
- A phase I study to determine the safety and pharmacokinetics of intravenous administration of TAS-106 once per week for three consecutive weeks every 28 days in patients with solid tumors.. 32:1689-1696. 2012
- Retrospective study of patients with brain metastases from melanoma receiving concurrent whole-brain radiation and temozolomide.. 31:4537-4543. 2011
- Evidence for the efficacy of Iniparib, a PARP-1 inhibitor, in BRCA2-associated pancreatic cancer.. 31:1417-1420. 2011
- A phase II study of capecitabine, oxaliplatin, bevacizumab and cetuximab in the treatment of metastatic colorectal cancer.. 31:255-261. 2011
- Corticorelin acetate, a synthetic corticotropin-releasing factor with preclinical antitumor activity, alone and with bevacizumab, against human brain tumor models.. 30:5037-5042. 2010
- A phase I dose-escalation study of imatinib mesylate (Gleevec/STI571) plus capecitabine (Xeloda) in advanced solid tumors.. 30:1251-1256. 2010
- A case of curative-intent hepatectomy for colon cancer metastatic to the scapula and liver.. 30:677-679. 2010
- Phase I dose escalation study of gemcitabine plus irinotecan in advanced solid tumors.. 29:5149-5153. 2009